Back
Gold Resource 10K Form
Sell
20
GORO
Gold Resource
Last Price:
0.13
Seasonality Move:
3.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | GORO/Gold Resource Quarterly |
2023-11-07 | 10Q | GORO/Gold Resource Quarterly |
2023-07-26 | 10Q | GORO/Gold Resource Quarterly |
2023-04-25 | 10Q | GORO/Gold Resource Quarterly |
2022-11-01 | 10Q | GORO/Gold Resource Quarterly |
2022-07-28 | 10Q | GORO/Gold Resource Quarterly |
Receive GORO News And Ratings
See the #1 stock for the next 7 days that we like better than GORO
GORO Financial Statistics
Sales & Book Value
Annual Sales: | $97.73M |
---|---|
Cash Flow: | $-2.08M |
Price / Cash Flow: | 0 |
Annual Sales: | $0.73 |
Price / Book: | 0.2 |
Profitability
EPS (TTM): | -0.46450 |
---|---|
Net Income (TTM): | $-42.15M |
Gross Margin: | $-5.32M |
Return on Equity: | -45.55% |
Return on Assets: | -23.16% |
Gold Resource Earnings Forecast
Key Gold Resource Financial Ratios
- The Gross Profit Margin over the past 20 years for GORO is -5.44%.
- The Selling, General & Administrative Expenses for GORO have been equal to 7.43% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -9.15% of Operating Income.
- The Net Earning history of GORO is -16.39% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 6 years.
Gold Resource Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | GORO |
CUSIP: | 38068T |
Website: | goldresourcecorp.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 2.17 |
Quick Ratio: | 0.81 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
GORO Technical Analysis vs Fundamental Analysis
Sell
20
Gold Resource (GORO)
is a Sell
Is Gold Resource a Buy or a Sell?
-
Gold Resource stock is rated a Sell
The current Gold Resource [GORO] share price is $0.13. The Score for GORO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.